AML is defined by an infiltration of the BM by immature blast cells superior to 20% while CML is characterised the bcr/abl fusion protein resulting from the translocation t(9:22) [31]. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.